AbbVie’s Rinvoq approved by European Commission for non-segmental vitiligo
Rinvoq is the first and only systemic medication approved in the EU for NSV
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Pfizer announces phase 3 results for nonsegmental vitiligo treatment
Litfulo delivered significant, clinically meaningful improvements for both face and body
Lilly to acquire AtaiBeckley in deal worth $2.8bn
The acquisition will advance therapies for treatment-resistant depression and other mental health conditions
AbbVie’s Rinvoq approved by European Commission for non-segmental vitiligo
Rinvoq is the first and only systemic medication approved in the EU for NSV
Cases of skin cancer set to reach 263,000 in 2035 according to new report
The report forecasts a rise in cases in the US, the UK, Canada, Australia and Europe
MAD World Summit 2026: where the future of workplace well-being takes centre stage
The event takes place on Thursday 26 November 2026 in the heart of London at Convene, 155 Bishopsgate
Latest content
Former Serviceplan Health Managing Partner launches new consultancy
Florian Bernsdorf launches new venture to advise CEOs and CMOs
Read More
Havas Lynx expands Claire Knapp’s remit to oversee Havas Lynx New York
In addition, Bruno Rebelo is appointed to the NY office as Chief Creative Officer
Read More
ELRIG appoints Hitesh Sanganee and Marcus Schindler to Scientific Advisory Board
Sanganee and Schindler previously held senior leadership roles at AstraZeneca and Novo Nordisk, respectively
Read More
Stoke Therapeutics appoints Thomas McCauley as Chief Scientific Officer
McCauley most recently served as the President and CEO of Neptune Bio
Read More
Intelligence
Forging a connection through creativity
A spark of creativity can cut through complexity, adding real value and helping to forge true connections with patients
Read More
The UK’s life sciences’ crossroads: competing in a market defined by speed, scale and investment
The UK’s challenge is less about capability and more about how well it aligns with the way global pharma now operates
Read More
Launching into an AI-powered future: a prescription for success
Making launch more effective, precise, cost-effective and agile demands new thinking and new technologies
Read More
ASCO 2026: the art of translation
Translating emerging science into care that works meaningfully in practice
Read More
Steering generative AI into the pharma fast lane
Industry needs to press the accelerator to adopt AI across functions to
supercharge launch excellence
Bridging the gap between European brain innovation and real-world policy
Aligning policy and public funding strategies to support brain health across Europe
Read More
Blogs
Latest
Moving Beyond the Pill: Unlocking Value Through Engaged, Empowered, and Educated Patients
July 30, 2026 | Impetus Digital|Health Outcomes, Impetus Digital, Market Access, Medical Innovation, PSP, Pharma Strategy, Value-based care, beyond the pill, digital health, digital voice, health innovation, health literacy, patient activation, patient engagement, patient support program, patientcentricity, real world data, treatment adherence
True “beyond-the-pill” strategy requires shifting from a prescriptive model to a supportive one—using personalized digital tools and authentic patient voices to drive adherence, improve outcomes, …
The Heart of the Matter: Medscape Education’s Cardiology Footprint at ESC 2026
July 28, 2026 | Medscape Education|CME, Cardiology Education, IME, Patient Impact, cardiology
For more than 30 years, Medscape Education has built independent, accredited cardiovascular education designed around one goal: improved patient outcomes. This year at the European …
What do patient stories actually teach us?
July 21, 2026 | Mednet|Making Health Whole, Patient Stories, health communications, marketing strategy, medcomms
How do we translate individual experiences into support that helps others and create support that feels personal but remains relevant to many?
More Than Pink Walls: What Women-Centric Care Actually Requires
July 15, 2026 | Medscape Education|
The phrase “patient-centered care” is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the population, that promise routinely fractures. In the …
Real Chemistry Launches Real Chemistry ANATOMI, an AI Ecosystem Purpose-Built for Healthcare Commercialization
July 14, 2026 | Real Chemistry|AI, Innovation, healthcarecommunications
The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of business growth and client value
A seat at the table: what the EU HTA reforms really ask of patient involvement
July 24, 2026 | Cuttsy + Cuttsy|EU HTA, Patient involvement, clinical trials, design
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at …
Infographic: Are data blind spots putting your launch at risk?
July 16, 2026 | Inizio|AI, Pharma, Product Launch, healthcare
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult …
Why faster trials make participant understanding more important than ever
July 15, 2026 | Cuttsy + Cuttsy|Informed Consent, clinical trials, communication
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants reject bad design, not technology
July 8, 2026 | Cuttsy + Cuttsy|Digital, clinical trials, communication, design
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.